中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

非酒精性脂肪肝与胰岛素抵抗

马丽娜 冯明 周英智 马佳 郝鹏

引用本文:
Citation:

非酒精性脂肪肝与胰岛素抵抗

详细信息
  • 中图分类号: R575.5;R587.1

The relationship between nonalcoholic fatty liver disease and insulin resistance

  • 摘要: 目的探讨非酒精性脂肪性肝病(NAFLD)与胰岛素抵抗(IR)的关系。方法NAFLD组52例,非NAFLD组50例,比较两组间BMI、WHR、TC、TG、CRP、HDL-C、LDL-C、ALT、Cr、FBG、FINS和HOMA-IR的差异,并进行Logistic回归分析。结果NAFLD组与非NAFLD组在BMI(26.7±2.3与22.4±2.5,P<0.01)、WHR(0.94±0.06与0.83±0.05,P<0.01)、TG(2.4±0.6与1.8±0.6,P<0.01)、ALT(37.3±8.3与28.1±7.2,P<0.05)、FBG(6.2±1.4与5.2±0.7,P<0.01)、FINS(23.6±13.6与8.6±3.5,P<0.01)、HOMA-IR(6.7±4.7与2.0±1.6,P<0.01)的差异有统计学意义,Logistic回归分析显示BMI(P<0.01)、WHR(P<0.01)、TG(P<0.01)、ALT(P<0.05)、HOMA-IR(P<0.01)是NAFLD的独立影响因素。结论B...

     

  • [1]Angulo P.Obesity and nonalcoholic fatty liver disease[J].Nutr Rev, 2007, 65 (S1) :S57-63.
    [2]Grant LM, Lisker MM.Nonalcoholic fatty liver disease[J].Ann Hepatol, 2004, 3 (3) :93-99.
    [3] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南[J].中华肝脏杂志, 2006, 14 (2) :161-163.
    [4]Bedogni G, Bellentani S.Fatty liver, howfrequent is it and why[J].Ann Hepatol, 2004, 3 (2) :63-65.
    [5]Fan JG, Zhu J, Li XJ, et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.
    [6]Gupte P, Amarapurkar D, Agal S, et al.Non-alcoholic steatohepa-titis in type2diabetes mellitus[J].Gastroenterol Hepatol, 2004, 19 (8) :854-858.
    [7]Methta K, van Thiel DH, Shah N, et al.Nonalcoholic fatty liver dis-ease:pathogenesis and the role of antioxidants[J].Nutr Rev, 2002, 60 (9) :289-293.
    [8]何淑梅, 孔俭, 牛俊奇.非酒精性脂肪性肝病研究现状及进展[J].中国老年学杂志, 2008, 28 (4) :725-727.
    [9]展玉涛.非酒精性脂肪肝与心血管疾病[J].中华内科杂志, 2007, 46 (10) :868-869.
    [10]Clark JM, Brancati FL, Diehl AM.The prevalence and etiology of elevated aminotransferase levels in the United States[J].Am J Gas-troenterol, 2003, 98 (5) :960-967.
    [11]Schindhelm RK, Diamant M, Jacqueline M, et al.Alanine amin-otransferase as a marker of non-alcoholic fatty liver disease in rela-tion to type2diabetes mellitus and cardiovascular disease[J].Dia-betes Metab Res Rev, 2006, 22 (6) :437-443.
    [12]Choudhury J, Sanyal AJ.Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease[J].Clin Liver Dis, 2004, 8 (3) :575-594.
    [13]Newschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome[J].Am J Med Sci, 2005, 330 (6) :326-335.
    [14]Bansilal S, Farkouh ME, Fuster V.Role of insulin resistance and hyperglycemia in the development of atherosclerosis[J].Am J Car-diol, 2007, 99 (4A) :6B-14B.
    [15]Bradbury MW.Lipid metabolism and liver inflammation.Hepatic fatty acid uptake:possible role in steatosis[J].Am J Physiol Gas-trointest Liver Physiol, 2006, 290 (2) :G194-G198.
  • 加载中
计量
  • 文章访问数:  3367
  • HTML全文浏览量:  29
  • PDF下载量:  1265
  • 被引次数: 0
出版历程
  • 出版日期:  2010-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回